Type 2 & other diabetes

Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study

Diabetes MetabPublished Nationwide hospital cohort study

Authors' conclusion

Patients with T2DM represent almost half of patients with CRS and are younger than their non-diabetic counterparts. T2DM doubles the risk of CRS and increases the risk of death, cardiovascular outcome, and end-stage kidney disease but not ischemic stroke after CRS.

Study context

Population
Adults hospitalized in France in 2012 with ≥5 years of follow-up, without cardiorenal syndromematched cohort
Participants
5,123,193 adults
Exposure
T2D vs no T2D
  • T2DMn = 380,581
  • Without T2DMn = 380,581reference
Outcome
Incident cardiorenal syndrome (CRS; cardiorenal, renocardiac and simultaneous subtypes)
Methodological details1:1 propensity matching
  • 1:1 propensity matching

Main finding

As reported in the abstract

Incident CRS

T2D

1.30%/year

No T2D

0.65%/year

Estimate (95% CI)
T2Dvs No T2D
aHR, any CRS 2.14(2.10–2.19)
T2Dvs No T2D
aHR, renocardiac 2.43(2.34–2.53)
T2Dvs No T2D
aHR, cardiorenal 2.09(2.03–2.15)
T2Dvs No T2D
aHR, simultaneous 1.94(1.86–2.03)
Cardiorenal syndrome (CRS) occurred during follow-up
104,788 patients

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)T2Dvs No T2DaHR, end-stage kidney disease 1.50 (CI 1.39–1.62)
Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)T2Dvs No T2DaHR, MI 1.35 (CI 1.19–1.53)
Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)T2Dvs No T2DaHR, cardiovascular death 1.20 (CI 1.13–1.27)
Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)T2Dvs No T2DaHR, HF 1.17 (CI 1.12–1.21)
Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)T2Dvs No T2DaHR, all-cause death 1.09 (CI 1.06–1.13)

Outcomes after prevalent CRS in 2012 (8,314 T2D matched to 8,314 without)

No increased risk of ischemic stroke

T2D among adults with CRS in 2012

Adults with CRS who had T2D (of 26,396)
11,355 (43.0%)
Age, T2D vs non-diabetic
77.4 ± 9.5 versus 82.3 ± 10.0

Original publication

Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study. Diabetes Metab. Published 15 March 2023. doi:10.1016/j.diabet.2023.101441

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.